Drug Testing Integrity

◦ Lab profits are based on rapid negative test
results
◦ Everyone loves negative tests
◦ Regulatory emphasis on costs of regulations
◦ Technical mistakes and leadership failures –
• The substituted-specimen fiasco
◦ Privacy concerns prohibit observed collection
without “individualized suspicion”
◦ HHS Mandatory Guidelines – All adulterated
tests are now “invalids”
Fostering the Growth of
the Beat-the
the-Test
Industry
7